Parallel-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-08
Total Holdings
3,520
Total Value
4434574142
Accession Number
0001690010-25-000004
Form Type
13F-HR
Manager Name
Parallel-Advisors
Data Enrichment
80% identified
2,826 identified694 unidentified

Holdings

3,520 positions • $4.4B total value
Manager:
Search and click to pin securities to the top
Page 164 of 176
Custom Truck One Source, Inc.
Shares:98
Value:$414
% of Portfolio:0.0% ($414/$4.4B)
DXP ENTERPRISES INC
Shares:5
Value:$411
% of Portfolio:0.0% ($411/$4.4B)
Centuri Holdings, Inc.
Shares:25
Value:$410
% of Portfolio:0.0% ($410/$4.4B)
45782B104
Shares:50
Value:$409
% of Portfolio:0.0% ($409/$4.4B)
CoreCivic, Inc.
Shares:20
Value:$406
% of Portfolio:0.0% ($406/$4.4B)
Star Bulk Carriers Corp.
Shares:26
Value:$405
% of Portfolio:0.0% ($405/$4.4B)
Critical Metals Corp.
Shares:291
Value:$404
% of Portfolio:0.0% ($404/$4.4B)
46435G672
Shares:8
Value:$400
% of Portfolio:0.0% ($400/$4.4B)
Vanda Pharmaceuticals Inc.
Shares:87
Value:$399
% of Portfolio:0.0% ($399/$4.4B)
SONIC AUTOMOTIVE INC
Shares:7
Value:$399
% of Portfolio:0.0% ($399/$4.4B)
EZCORP INC
Shares:27
Value:$397
% of Portfolio:0.0% ($397/$4.4B)
IMAX CORP
Shares:15
Value:$395
% of Portfolio:0.0% ($395/$4.4B)
Kalaris Therapeutics, Inc.
Shares:49
Value:$393
% of Portfolio:0.0% ($393/$4.4B)
DNOW Inc.
Shares:23
Value:$393
% of Portfolio:0.0% ($393/$4.4B)
SUPERNUS PHARMACEUTICALS, INC.
Shares:12
Value:$393
% of Portfolio:0.0% ($393/$4.4B)
Quince Therapeutics, Inc.
Shares:295
Value:$392
% of Portfolio:0.0% ($392/$4.4B)
Taysha Gene Therapies, Inc.
Shares:280
Value:$389
% of Portfolio:0.0% ($389/$4.4B)
Braemar Hotels & Resorts Inc.
Shares:156
Value:$388
% of Portfolio:0.0% ($388/$4.4B)
COMPASS Pathways plc
Shares:134
Value:$383
% of Portfolio:0.0% ($383/$4.4B)
SI-BONE, Inc.
Shares:27
Value:$379
% of Portfolio:0.0% ($379/$4.4B)